Conversely, in cancers like oral squamous cell carcinoma (OSCC), esophageal squamous cell carcinoma (ESCC), and prostate cancer, decreased CSTA expression is frequently observed and strongly associated with aggressive tumor phenotypes, as well as high tumor grades, nodal metastasis, and poor overall survival [29,30]. Here, CSTA is linked to prostate cancer.